This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (39)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Leo E. Hollister, MD; John E. Overall, PhD; Isham Kimbell, Jr., MD; Alex Pokorny, MD

Arch Gen Psychiatry. 1974;30(1):94-99.

Abstract
A total of 320 newly admitted schizophrenic men were randomly assigned to either an aliphatic, piperidine, or piperazine phenothiazine. Physicians chose drugs within the class assigned and used them to maximal clinical advantage. None of the drug classes was superior to another in total efficacy.

Finer differences were that piperazines were more effective in patients who were older and who were categorized as having "core" or "nonparanoid" types of schizophrenia, characterized chiefly by thought disorders. The prevailing belief that these drugs are more specific antipsychotic agents was given some support.

Past difficulties in replicating specific indications for antipsychotic drugs, as well as the few differences found in this study, force the clinician still to choose drugs empirically. Differing reactions of individual patients to various drugs are more likely due to differences in drug kinetics than to any important pharmacological differences.

Author Affiliations
Palo Alto, Calif; Galveston, Tex; Dallas; Houston

From the Veterans Administration Hospitals, Palo Alto, Calif (Dr. Hollister), Dallas (Dr. Kimbell), Houston (Dr. Pokorny), and the University of Texas Medical Branch, Galveston (Dr. Overall).

Footnotes
Accepted for publication July 9, 1973.

Reprint requests to the Veterans Administration Hospital, 3801 Miranda Ave, Palo Alto, CA 94304 (Dr. Hollister).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Span of Apprehension Deficits During the Postpsychotic Stages of Schizophrenia: A Replication and Extension
Asarnow and MacCrimmon
Arch Gen Psychiatry 1981;38:1006-1011.
ABSTRACT  

Treatment of Secondary Depression in Schizophrenia: A Double-blind, Placebo-Controlled Trial of Amitriptyline Added to Perphenazine
Prusoff et al.
Arch Gen Psychiatry 1979;36:569-575.
ABSTRACT  

Variability in Schizophrenia: Reflection of a Regulatory Disease
van der Velde
Arch Gen Psychiatry 1976;33:489-496.
ABSTRACT  

Amitriptyline-Perphenazine Interaction in Ambulatory Schizophrenic Patients: A Controlled Study of Drug Interaction
Chouinard et al.
Arch Gen Psychiatry 1975;32:1295-1307.
ABSTRACT